openPR Logo
Press release

Carcinoembryonic Antigen (CEA) Market - Latest Global Insights on Technology, Growth Factors | Key Players are: Quest Diagnostics, Roche Diagnostics, Abbott Diagnostics, GenWay Biotech Inc, Correlogic Systems, Inc

09-17-2018 02:23 PM CET | Health & Medicine

Press release from: Global Market Insights

Carcinoembryonic Antigen (CEA) Market

Carcinoembryonic Antigen (CEA) Market

The Carcinoembryonic Antigen Market will exceed USD 2.7 billion by 2023 as per a new research report.
Rising technological advancements and adoption of cutting-edge technologies in order to offer better solutions to early diagnosis of various cancer types should fuel carcinoembryonic antigen market over the forecast timeline.

Surge in cancer prevalence should create lucrative opportunities in the coming years. As per, World Cancer Research Fund International (WCRFI), approximately 1.4 million new colorectal cancer cases diagnosed in 2012, it is third most common cancer across the globe. Dramatic changes in dietary habits, high liquor intake, sedentary lifestyle, and exposure to radioactive elements should drive the market growth in the future. Colorectal cancer will dominate the revenue share over the forecast period, due to increased prevalence of colorectal cancer globally.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/427

Breast cancer segment is witnessed highest growth rate over the forecast time frame. Increased prevalence of breast cancer, favorable government policies to early diagnosis, adoption of novel biomarkers are few factors rendering the market growth.

U.S. carcinoembryonic antigen market was over 70% of regional revenue share in 2015. Increasing prevalence of cancer, rising awareness levels coupled with adoption of cutting-edge diagnostic technologies will fuel the market growth over the forecast timeline.

UK carcinoembryonic antigen market will grow at significant CAGR over the coming years. Rising prevalence of cancer, favorable government initiatives to early diagnose the cancer, adequate reimbursement policies will witness carcinoembryonic industry growth. For instance, National Awareness and Early Diagnosis Initiative (NAEDI) led by Cancer Research UK in alliance with Public Health England, and NHS England to enhance the awareness on early diagnosis of cancer.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/427

China carcinoembryonic antigen market will dominate regional revenue share in the future. Surge in cancer prevalence, rising geriatric population, increased disposable income, increased awareness levels, adoption of advanced diagnostic methods, increased government spending on biotech industry should foster the revenue growth over the forecast timeline.

Rising prevalence cancer, favorable government initiatives should foster market growth in India. Increased healthcare expenditure, adoption of state-of-art technologies and cost-effective treatment enables create demand for medical tourism. Large patient pool, government support to early diagnosis of cancer will boost the market growth in the future.

Brazil carcinoembryonic market is dominated the revenue share in 2015, due to increased lung cancer prevalence in Brazil, rising awareness levels, availability of sophisticated healthcare technologies in the country.

Limited awareness, inadequate reimbursement policies, and untapped markets in low income countries will create lucrative opportunities in the future.

Key Players are:

Some industry players are Roche Diagnostics, Lifespan Bioscience, Inc., Abbott Diagnostics, Quest Diagnostics, GenWay Biotech, and DRG diagnostics. Industry players are entering in strategic collaborations and robust R&D investments to offer novel products are the major strategies. Favorable government regulations, increased adoption novel detection methods are expected to create good opportunities for companies.

Chapter 3. Carcinoembryonic antigen Industry Insights

3.1. Industry segmentation

3.2. Industry size and forecast, 2012 - 2023

3.3. Industry impact forces

3.3.1. Growth drivers

3.3.1.1. Growing elderly population base

3.3.1.2. Minimally invasive diagnostic procedure demand

3.3.1.3. Increasing cancer prevalence

3.3.1.4. Combination biomarker adoption surge

3.3.1.5. Healthcare expenditure trends

3.3.1.6. CEA usage in cancer

3.3.2. Industry pitfalls & challenges

3.3.2.1. Complex regulatory landscape

3.3.2.2. Ineffectiveness in detecting cancer at early stages

3.4. Growth potential benchmarking

3.5. Company market share analysis, 2015

3.5.1. Strategy dashboard

3.6. Porter’s analysis

3.7. PESTEL analysis

CEA market by application :

CEA based colorectal cancer
CEA based pancreatic cancer
CEA based ovarian cancer
CEA based breast cancer
CEA based thyroid cancer

Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Carcinoembryonic Antigen (CEA) Market - Latest Global Insights on Technology, Growth Factors | Key Players are: Quest Diagnostics, Roche Diagnostics, Abbott Diagnostics, GenWay Biotech Inc, Correlogic Systems, Inc here

News-ID: 1242731 • Views:

More Releases from Global Market Insights

Acoustic Diaphragm Market slated to observe traction for polypropylene material in earphones & loudspeakers
Acoustic Diaphragm Market slated to observe traction for polypropylene material …
With a seismic rise in the demand for consumer products such a loudspeakers, mobile phones and earphones, acoustic diaphragm market size is slated to surge in the next five years. Notably, acoustic diaphragm tends to inter-convert mechanical vibration to sounds and has become highly popular in headphones and speakers. Market penetration of materials such as paper, polycarbonate, polypropylene, carbon fiber and aluminum has become more pronounced in the past several
How will increasing demand for stainless steel transform the Ferroalloys Market outlook?
How will increasing demand for stainless steel transform the Ferroalloys Market …
One of the recent breakthroughs in the global ferroalloys market is the potential acquisition of Ferro Alloys Corporation by Vedanta- a natural resource company early this year. As per reliable sources, the acquisition is expected to complement Vedanta’s current steel business considering the fact that integration of Ferro manufacturing capabilities would offer the possibility to generate significant efficiencies. Meanwhile, yet other company, Boston Metal has declared having raised over USD 20
Polyphenylsulfone Market 2021 | Regional Insights & Growth Forecast To 2025
Polyphenylsulfone Market 2021 | Regional Insights & Growth Forecast To 2025
The polyphenylsulfone market will witness significant expansion with the rise in healthcare concerns and the growing requirement for biocompatible products. Polyphenylsulfone is a high-performance thermoplastic that is amorphous, heat-resistant, and transparent. It showcases high sterilization properties and is widely employed as an alternative for polyetheretheketone and polyaryletherketone. Furthermore, the polymer sees large adoption across various verticals of the healthcare sector to offer superior dimensional stability and higher resistance against
Cosmetic Contact Lens Market 2021: Industry Growth, Competitive Analysis, Future Prospects and Forecast 2024
Cosmetic Contact Lens Market 2021: Industry Growth, Competitive Analysis, Future …
Increasing trend of using colored contact lenses may have a positive impact on cosmetic contact lens market outlook. Rising popularity of customized lenses with attractive colors, shades and textures for improving eye appearance is likely to propel industry size. Proliferation of entertainment, online and social media platforms are helping boost the adoption of such lenses. Cosmetic contact lenses are available in several colors such as blue, green, brown, hazel, grey, violet

All 5 Releases


More Releases for CEA

Carcinoembryonic Antigen (CEA) Market Size, Share | Industry Report 2026
The global Carcinoembryonic Antigen (CEA) Market was valued at $5.3 Billion in 2018 and is forecast to grow at a modest 6.1 % CAGR between 2018 and 2026, culminating in 2026 global sales of $ 9.2 Billion. Carcinoembryonic AntigenTest is a blood test which identifies the diagnose and manage certain cancer disease like rectum and large intestine. Basically, it is used to check how well treatment is working in certain
Carcinoembryonic Antigen (CEA) Market Investment Research Report 2017 – 2027
Carcinoembryonic antigen (CEA) is normally found in embryonic entodermal epithelium. Carcinoembryonic antigen is a group of glycoprotein present in the body fluids of the fetus and embryo and in the gastrointestinal tract. Carcinoembryonic antigen is also present in the mucosal cells of the colorectum, gastrointestinal cells, and small amounts are present in the blood. Carcinoembryonic antigen is produced by the gastrointestinal tissues during the development of fetal. CEA is not
CEA Testing Market Progresses For Huge Profits During 2019
Carcinoembryonic antigen (CEA) is a protein usually produced in the developing fetus and disappears or is absent in adults. Abnormal amounts of this protein may lead to cancer. CEA test is performed to measure the level of proteins and check for the recurrence of colon and other cancers in patients already diagnosed with cancer. The normal accepted range of this protein is 0 micrograms to 0.25 micrograms per liter. Elevated
Releases New Report on the CEA Antibodies Market
CEA stands for carcinoembryonic antigen, is a protein that is usually produced in developing fetus and disappears or is absent in adults. Production of abnormal amount of CEA protein may lead to cancer. CEA test is performed to measure the level of proteins and check for the recurrence of colon and other cancers in patients already diagnosed with cancer. The normal accepted range of this protein that is non-cancerous in
CEA Testing Market Intelligence with Competitive Landscape 2019
Carcinoembryonic antigen (CEA) is a protein usually produced in the developing fetus and disappears or is absent in adults. Abnormal amounts of this protein may lead to cancer. CEA test is performed to measure the level of proteins and check for the recurrence of colon and other cancers in patients already diagnosed with cancer.  The normal accepted range of this protein is 0 micrograms to 0.25 micrograms per liter. Elevated
Carcinoembryonic Antigen (CEA) Market to hit $2.7bn by 2023
Carcinoembryonic Antigen (CEA) Market size is driven by increasing incidence rate for cancer disease especially colorectal cancer is one of the important factor contributing to the growth. Global Carcinoembryonic Antigen Market is set to register profitable growth in the near future and surpass USD 2.8 billion by 2023. This growth is attributed to factors including consistent technology advancements, development of novel biomarkers and growing prevalence of cancer. Global Market Insights,